[PDF][PDF] Average daily ischemic vs. bleeding risk in patients with ACS undergoing PCI: Insights from the Bleemacs and Renami Registries

IX Velicki, L Correia, E Cerrato, A Rognoni, U Fabrizio… - 2024 - iris.unito.it
Introduction. The risk of recurrent ischemia and bleeding after percutaneous coronary
intervention (PCI) for acute coronary syndrome (ACS) may vary during the firstyear of follow …

Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: insights from the BleeMACS and RENAMI registries

F D'Ascenzo, C Biolè, S Raposeiras-Roubin… - American heart …, 2020 - Elsevier
Background The risk of recurrent ischemia and bleeding after percutaneous coronary
intervention (PCI) for acute coronary syndrome (ACS) may vary during the first year of follow …

Predicting risk for bleeding after PCI: Another step in the right direction but work remains

U Baber - International Journal of Cardiology, 2018 - internationaljournalofcardiology.com
Once considered a secondary and unavoidable complication of antithrombotic therapy after
percutaneous coronary intervention (PCI), bleeding is now recognized as an important …

The balance between bleeding and ischaemic complications in percutnaeous coronary intervention practice

D Antoniucci - European heart journal supplements, 2008 - academic.oup.com
Strong antithrombotic treatments may decrease the risk of recurrent ischaemic events in
patients with acute coronary syndromes (ACS) and, as adjunctive therapy to percutaneous …

Annual vascular and bleeding outcomes in East Asian poststenting patients with acute coronary syndrome: The BRIC-ACS II trial

D Li, Y Yu, Y Chen - Cardiovascular Research, 2024 - academic.oup.com
Abstract Funding Acknowledgements Type of funding sources: None. Main funding source
(s): no Objective We aim to determine the incidence of events in the 'real-world'ACS Chinese …

Effects of acute coronary syndrome and stable coronary artery disease on bleeding and ischemic risk after percutaneous coronary intervention

M Natsuaki, T Morimoto, H Shiomi, K Kadota… - Circulation …, 2021 - jstage.jst.go.jp
Background: Data evaluating the effects of acute coronary syndrome (ACS) relative to stable
coronary artery disease (CAD) on bleeding risk after percutaneous coronary intervention …

A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC‐ACS study

Y Chen, T Yin, S Xi, S Zhang, H Yan… - Catheterization and …, 2019 - Wiley Online Library
Background Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI)
prevents ischemic events while increasing bleeding risk. Real‐world‐based metrics to …

Annual Vascular and Bleeding Outcomes in East Asian Poststenting Patients With Acute Coronary Syndrome: The BRIC-ACS II Trial

D Li, Y Chen, Y Yu, X Tuo - Circulation, 2023 - Am Heart Assoc
Objective: To determine the incidence of bleeding and thrombotic vascular events in the"
real-world" acute coronary syndromes (ACS) Chinese patients over 1-year following stent …

Long-term outcomes in high-bleeding risk patients undergoing PCI for acute coronary syndromes: results from a large single-center pci registry

J Nicolas, D Cao, B Claessen, S Sartori… - European Heart …, 2020 - academic.oup.com
Introduction Current clinical guidelines recommend prolonged dual antiplatelet therapy
(DAPT) following percutaneous coronary intervention (PCI) in patients presenting with acute …

Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI

G Giustino, R Mehran, GD Dangas, AJ Kirtane… - Journal of the American …, 2017 - jacc.org
Background: The risk of recurrent ischemic and bleeding events after primary percutaneous
coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) may not …